Neurodevelopmental outcomes after hypothermia therapy in the era of Bayley-III

L. F. Chalak, T. L. Dupont, P. J. Sánchez, A. Lucke, R. J. Heyne, M. C. Morriss, N. K. Rollins

Research output: Contribution to journalArticlepeer-review

34 Scopus citations


Objective:Bayley-III scales are currently used to evaluate outcomes of term infants following hypothermia therapy, while all before reported outcomes in this population have used Bayley-II. Our objectives were to determine the incidence of abnormal neurodevelopmental outcomes using Bayley III and the predictive value of Magnetic resonance imaging (MRI) in infants who received systemic hypothermia.Study Design:We conducted a prospective cohort study of inborn infants who underwent hypothermia for moderate/severe neonatal encephalopathy from October 2005-November 2011.Result:Eighty newborns underwent hypothermia (incidence of 1/1000). Of the survivors, 89% had Bayley-III performed around 24 months of age. An abnormal outcome using Bayley-III <85 occurred in 50%, while Bayley III <70 occurred in 13%. MRI predicted Bayley III<85 with sensitivity of 73%, specificity of 84%, positive-predictive value of 84% and negative-predictive value of 74%.Conclusion:A Bayley-III 85 cutoff identifies a disability rate of 50%, and MRI was predictive of abnormal outcomes. Findings can be useful for counseling of families and planning of future studies using Bayley III.

Original languageEnglish (US)
Pages (from-to)629-633
Number of pages5
JournalJournal of Perinatology
Issue number8
StatePublished - Aug 2014

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology


Dive into the research topics of 'Neurodevelopmental outcomes after hypothermia therapy in the era of Bayley-III'. Together they form a unique fingerprint.

Cite this